Every year many people die from melanoma, a serious form of skin cancer. Although being lethal, this cancer can be cured and its prognosis can be controlled with early diagnosis. The thickness of the tumour often referred to as Breslow's tumour thickness, is a crucial factor in determining the stage of this cancer.
My current project funded by Research Council of Norway focus on analysing the melanoma incidence and its trend over 35-years by clinicopathologic prognostic factors such as tumour thickness and clinical stage, and demographic prognostic factors such as sex and age. Further we are also exploring the long and short term survival and mortality due to melanoma by tumour thickness. The aim is to identify the factors affecting the melanoma incidence and survival. This can make a huge difference in guiding treatment plans through targeted screening, risk assessment and managing patients follow-up.